WCBA
RMD icon

Weaver C. Barksdale & Associates’s ResMed RMD Stock Holding History

Weaver C. Barksdale & Associates’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-140
Closed -$11K – 497
2017
Q2 		$11K Sell
140
-5
-3% -$358 0.01% 253
2017
Q1 		$10K Sell
145
-26
-15% -$1.8K 0.01% 278
2016
Q4 		$11K Buy
171
+31
+22% +$1.9K 0.02% 261
2016
Q3 		$9K Hold
140
– – 0.02% 286
2016
Q2 		$9K Buy
140
+20
+17% +$1.18K 0.02% 268
2016
Q1 		$7K Hold
120
– – 0.01% 341
2015
Q4 		$6K Sell
120
-17
-12% -$958 ﹤0.01% 352
2015
Q3 		$7K Buy
137
+11
+9% +$592 0.01% 324
2015
Q2 		$7K Buy
126
+31
+33% +$1.96K 0.01% 335
2015
Q1 		$7K Sell
95
-25
-21% -$1.62K 0.01% 339
2014
Q4 		$7K Sell
120
-13
-10% -$679 0.01% 322
2014
Q3 		$7K Buy
133
+7
+6% +$357 0.01% 314
2014
Q2 		$6K Sell
126
-22
-15% -$1.09K ﹤0.01% 354
2014
Q1 		$7K Buy
148
+13
+10% +$584 0.01% 320
2013
Q4 		$6K Buy
135
+25
+23% +$1.26K 0.01% 354
2013
Q3 		$6K Sell
110
-9
-8% -$437 0.01% 353
2013
Q2 		$5K Buy
+119
New +$5.65K ﹤0.01% 374

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Weaver C. Barksdale & Associates's RMD Position: Q3 2017 in Review

Weaver C. Barksdale & Associates sold out of ResMed (RMD) in Q3 2017, closing a stake of 140 shares — an estimated $11K sold.

Weaver C. Barksdale & Associates first reported a position in RMD in Q2 2013 and held it in 17 quarters. The position peaked at $11K in Q2 2017. 362 funds tracked by Wall St. Rank hold RMD as of Q3 2017.

  • Weaver C. Barksdale & Associates reported no remaining ResMed position as of Q3 2017 after selling out during the quarter.
  • Weaver C. Barksdale & Associates sold 140 ResMed shares in Q3 2017, an estimated $11K.
  • Weaver C. Barksdale & Associates first reported a position in ResMed in Q2 2013 and held it in 17 quarters.
  • Weaver C. Barksdale & Associates's ResMed position peaked at $11K in Q2 2017.
  • 362 funds tracked by Wall St. Rank held ResMed as of Q3 2017.

Based on Weaver C. Barksdale & Associates's 13F filing for Q3 2017, filed 12 Oct 2017.